Overview

Comparison Levobupivacaine and Ropivacaine for TAP-block After Caesarean Section

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, controlled trial: a comparison of Levobupivacaine and Ropivacaine for postoperative analgesia using TAP-block Objectives: 1. VAS score during the first 12 hours 2. Determine which drug is more effective for postoperative analgesia in the first 12 hours after surgery 3. Side effects
Phase:
N/A
Details
Lead Sponsor:
Alexandr Ronenson
Treatments:
Bupivacaine
Levobupivacaine
Pharmaceutical Solutions
Ropivacaine